242 related articles for article (PubMed ID: 12956431)
1. The role of autoimmunity in the pathogenesis of lung allograft rejection.
Wilkes DS
Arch Immunol Ther Exp (Warsz); 2003; 51(4):227-30. PubMed ID: 12956431
[TBL] [Abstract][Full Text] [Related]
2. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection.
Sumpter TL; Wilkes DS
Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1129-39. PubMed ID: 15136293
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung.
Yoshida S; Iwata T; Chiyo M; Smith GN; Foresman BH; Mickler EA; Heidler KM; Cummings OW; Fujisawa T; Brand DD; Baker A; Wilkes DS
Transplantation; 2007 Mar; 83(6):799-808. PubMed ID: 17414715
[TBL] [Abstract][Full Text] [Related]
4. Humoral autoimmunity and transplant vasculopathy: when allo is not enough.
Win TS; Pettigrew GJ
Transplantation; 2010 Jul; 90(2):113-20. PubMed ID: 20531074
[TBL] [Abstract][Full Text] [Related]
5. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
[TBL] [Abstract][Full Text] [Related]
6. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.
Haque MA; Mizobuchi T; Yasufuku K; Fujisawa T; Brutkiewicz RR; Zheng Y; Woods K; Smith GN; Cummings OW; Heidler KM; Blum JS; Wilkes DS
J Immunol; 2002 Aug; 169(3):1542-9. PubMed ID: 12133982
[TBL] [Abstract][Full Text] [Related]
7. The role of autoimmunity in obliterative bronchiolitis after lung transplantation.
Weber DJ; Wilkes DS
Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L307-11. PubMed ID: 23262227
[TBL] [Abstract][Full Text] [Related]
8. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
9. Oral tolerance induction by type V collagen downregulates lung allograft rejection.
Yasufuku K; Heidler KM; O'Donnell PW; Smith GN; Cummings OW; Foresman BH; Fujisawa T; Wilkes DS
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):26-34. PubMed ID: 11472972
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.
Fildes JE; Yonan N; Leonard CT
Transpl Immunol; 2008 Apr; 19(1):1-11. PubMed ID: 18346631
[TBL] [Abstract][Full Text] [Related]
11. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
12. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
13. Impact of donor and recipient age on allograft tolerance.
Martins PN
Exp Clin Transplant; 2009 Jun; 7(2):67-77. PubMed ID: 19715510
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of lung-restricted antibodies in lung transplantation.
Akbarpour M; Wu Q; Liu X; Sun H; Lecuona E; Tomic R; Bhorade S; Mohanakumar T; Bharat A
Hum Immunol; 2019 Aug; 80(8):595-601. PubMed ID: 31078336
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts.
Nakashima S; Morikawa M; Komatsu K; Matsuura A; Sato N; Abe T
J Heart Lung Transplant; 2005 Apr; 24(4):462-9. PubMed ID: 15797749
[TBL] [Abstract][Full Text] [Related]
16. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
Yamada Y; Sekine Y; Yoshida S; Yasufuku K; Petrache I; Benson HL; Brand DD; Yoshino I; Wilkes DS
J Immunol; 2009 Jul; 183(1):237-45. PubMed ID: 19542435
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk of alloimmune response and autoimmunity: role in pathogenesis of chronic rejection.
Tiriveedhi V; Weber J; Seetharam A; Mohanakumar T
Discov Med; 2010 Mar; 9(46):229-35. PubMed ID: 20350490
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cells as targets of allograft rejection.
Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C
Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788
[TBL] [Abstract][Full Text] [Related]
19. The combined organ effect: protection against rejection?
Rana A; Robles S; Russo MJ; Halazun KJ; Woodland DC; Witkowski P; Ratner LE; Hardy MA
Ann Surg; 2008 Nov; 248(5):871-9. PubMed ID: 18948817
[TBL] [Abstract][Full Text] [Related]
20. Allograft rejection after lung transplantation.
Whelan TP; Hertz MI
Clin Chest Med; 2005 Dec; 26(4):599-612, vi. PubMed ID: 16263399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
